Transforming growth factor-β2 inhibition of corneal endothelial proliferation mediated by prostaglandin

Current Eye Research

Volumn 26, Issue 6, 2003, Pages 363-370

  Chen, Ko Hua ^a,b,c   Hsu, Wen Ming ^a,b   Chiang, Chien Cheng ^a,c   Li, Yen Shien ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Aqueous humor; Corneal endothelial cells; Indomethacin; Prostaglandin E2; Transforming growth factor 2

Indexed keywords

INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIUM, CORNEAL; INDOMETHACIN; MALE; OSMOLAR CONCENTRATION; RABBITS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 0042167360     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.26.5.363.15442     Document Type: Article

References (49)

1. Joyce NC, Meklir B, Joyce SJ, Zieske JD. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci. 1996;37:645-655.
2. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566-1575.
3. Chen KH, Harris DL, Joyce NC. TGF-beta 2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci. 1999;40:2513-2519.
4. Jumblatt MM. Autocrine regulation of corneal endothelium by prostaglandin E2. Invest Ophthalmol Vis Sci. 1994;35:2783-2790.
5. Kokawa N, Sotozono C, Nishida K, Kinoshita S. High total TGF-beta 2 levels in normal human tears. Curr Eye Res. 1996;15:341-343.
6. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res. 1990;10:963-969.
7. Majima K. Presence of growth factor in human vitreous. Ophthalmologica. 1997;211:226-228.
8. Howe PH, Draetta G, Leof EB. Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol. 1991;11:1185-1194.
9. Reddy KB, Hocevar BA, Howe PH. Inhibition of G1 phase cyclin dependent kinase by transforming growth factor-beta 1. J Cell Biochem. 1994;56:418-425.
10. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA. 1995;92:5545-5549.
11. Kim TY, Kim WI, Smith RE, Kay ED. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2001;42:3142-3149.
12. Gronwald RG, Seifert RA, Bowen-Pope DF. Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-beta. J Biol Chem. 1989;264:8120-8125.
13. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell. 1990;63:515-524.
14. Sylvia VL, Schwartz Z, Dean DD, Boyan BD. Transforming growth factor-beta1 regulation of resting zone chondrocytes is mediated by two separate but interacting pathways. Biochim Biophys Acta. 2000;1496:311-324.
15. Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, Polgar P. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun. 1993;30:1465-1474.
16. Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL et al. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia. 1999;1:508-517.
17. Pfeilschifter J, Pignat W, Leighton J, Marki F, Vosbeck K, Alkan S. Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells. Biochem J. 1990;15:269-271.
18. Kniss DA, Zimmerman PD, Fertel RH, Iams JD. Transforming growth factor-beta potentiates epidermal growth factor-induced prostaglandin E2 production in amnion cells. Prostaglandins. 1993;45:27-33.
19. Jumblatt MM, Willer SS. Corneal endothelial repair. Regulation of prostaglandin E2 synthesis. Invest Ophthalmol Vis Sci. 1996;37:1294-1301.
20. Jumblatt MM. PGE2 synthesis and response pathways in cultured corneal endothelial cells: The effects of in vitro aging. Curr Eye Res. 1997;16:428-435.
21. Maihofner C, Schlotzer-Schrehardt U, Guhring H, Zeilhofer HU, Naumann GO, Pahl A, Mardin C, Tamm ER, Brune K. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci. 2001;42:2616-2624.
22. Schlotzer-Schrehardt U, Zenkel M, Nusing RM. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci. 2002;43(5):1475-1487.
23. Klein-Nulend J, Semeins CM, Burger EH. Prostaglandin mediated modulation of transforming growth factor-beta metabolism in primary mouse osteoblastic cells in vitro. J Cell Physiol. 1996;168:1-7.
24. McAnulty RJ, Chambers RC, Laurent GJ. Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J. 1995;307:63-68.
25. Nishi O, Nishi K, Imanishi M, Tada Y, Shirasawa E. Effect of the cytokines on the prostaglandin E2 synthesis by lens epithelial cells of human cataracts. Br J Ophthalmol. 1995;79:934-938.
26. Diaz A, Varga J, Jimenez SA. Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J Biol Chem. 1989;15:11554-11557.
27. Sumitani K, Kawata T, Yoshimoto T, Yamamoto S, Kumegawa M. Fatty acid cyclooxygenase activity stimulated by transforming growth factor-beta in mouse osteoblastic cells (MC3T3-E1). Arch Biochem Biophys. 1989;1:588-595.
28. Berchuck A, MacDonald PC, Milewich L, Casey ML. Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells. Prostaglandins. 1989;38:453-464.
29. Hung WC, Chang HC, Pan MR, Lee TH, Chuang LY. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Mol Pharmacol. 2000;58:1398-1403.
30. Parnigotto PP, Conconi MT. Effects of prostaglandin E2 on growth, morphology, morphometry and keratin pattern of bovine corneal epithelial cells cultured in vitro. Anat Anz. 1998;180:511-518.
31. Kang SS, Li T, Xu D, Reinach PS, Lu L. Inhibitory effect of PGE2 on EGF-induced MAP kinase activity and rabbit corneal epithelial proliferation. Invest Ophthalmol Vis Sci. 2000;41:2164-2169.
32. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Spon MB. Type beta transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci USA. 1985;82:119-123.
33. Joyce NC, Joyce SJ, Powell SM, Meklir B. EGF and PGE2: Effects on corneal endothelial cell migration and monolayer spreading during wound repair in vitro. Curr Eye Res. 1995;14:601-609.
34. Harris DL, Joyce NC. Transforming growth factor-beta suppresses proliferation of rabbit corneal endothelial cells in vitro. J Interferon Cytokine Res. 1999;19:327-334.
35. Oliver MH, Harrison NK, Bishop JE, Cole PJ, Laurent GJ. A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessment of growth factors. J Cell Sci. 1989;92:513-518.
36. Chen KH, Hsu WM, Lee SM. Differential effects of transforming growth factor-beta2 on corneal endothelial cell proliferation-A role of serum factors. Exp Eye Res. 2002;75:61-67.
37. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ. Indomethacin suppresses the antiproliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J. 1997;1:639-643.
38. Rosner M, Gelerstein S, Weissman C, Naveh N. Prostaglandin E2 and protein levels in rabbit aqueous humor following ND:YAG laser iridotomy. Metab Pediatr Syst Ophthalmol. 1988;11:50-52.
39. Liu JH. Circadian variations of prostaglandins in the rabbit aqueous humor. J Ocul Pharmacol Ther. 2000;16:49-54.
40. Kulkarni PS, Mancino M. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res. 1993;56:275-279.
41. Ueda M, Sugatani J, Unezaki S, Ito Y, Miki H, Uyama M et al. Involvement of prostaglandin E2 in rabbit corneal injury by anterior segment ischaemia. Prostaglandins Leukot Essent Fatty Acids. 1997:57:285-291.
42. Cowlen MS, Eling TE. Effects of prostaglandins and hydroxyoctadecadienoic acid on epidermal growth factor-dependent DNA synthesis and c-myc proto-oncogene expression in Syrian hamster embryo cells. Biochim Biophys Acta. 1993;23:234-240.
43. Rock CO, Cleveland JL, Jackowski S. Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol. 1992;12:2351-2358.
44. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM et al. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 1990;1:777-785.
45. Zentella A, Weis FM, Ralph DA, Laiho M, Massague J. Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function. Mol Cell Biol. 1991;11:4952-4958.
46. Fukami J, Tsuji K, Ueno A, Ide T. Transforming growth factor-beta 1 has both promoting and inhibiting effects on induction of DNA synthesis in human fibroblasts. Exp Cell Res. 1995;216:107-112.
47. Jumblatt MM, Paterson CA. Prostaglandin E2 effects on corneal endothelial cyclic adenosine monophosphate synthesis and cell shape are mediated by a receptor of the EP2 subtype. Invest Ophthalmol Vis Sci. 1991;32:360-365.
48. Vassaux G, Gaillard D, Darimont C, Ailhaud G, Negrel R. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: Physiological implications. Endocrinology. 1992;131:2393-2398.
49. Rosado E, Schwartz Z, Sylvia VL, Dean DD, Boyan BD. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim Biophys Acta. 2002;1590:1-15.